Epic has a mortality model. Omada is building new products. And STAT+ subscribers get to read about both, because the newsletter opened with a writer whose two kids got sick after one week of school.
The story is exclusive to STAT+, the premium tier of STAT’s Health Tech newsletter.
The School Week That Started It All
It’s a small detail, but it works. The newsletter writer opens with a confession: their kids have been in school for one week, and everyone is already sick.
The irony is that a newsletter about health technology is being written by someone whose household is currently battling the common cold. It’s a humanising touch, and it lands well.
The newsletter then invites readers to sign up for its weekly delivery. It’s a gentle reminder that the service exists, and that it covers the intersection of technology and healthcare.
Epic’s Mortality Model
Epic is the electronic health record company. Its mortality model is a predictive tool, and the newsletter describes it as a signal that hospitals need to respond to.
It’s also the kind of thing that raises ethical questions. Who gets to know that a patient is at risk? How do you use that information without causing harm? The model is a warning system, and it requires a framework for how hospitals respond to its signals.
Omada’s Future Products
Omada is the digital health company that makes remote care software, and the newsletter hints that the company has new products in the pipeline. The story doesn’t say what those products are, but it suggests they’re coming.
The pairing of Epic and Omada in one newsletter is a deliberate choice. Epic’s model is about prediction and risk. Omada’s products are about intervention and care. Together, they illustrate the full spectrum of digital health: from the data that identifies problems to the tools that fix them.
The newsletter doesn’t say exactly what Omada’s new products are. It only says they’re coming. That leaves readers curious about what the company is building next.
The STAT+ Exclusive
The newsletter is exclusive to STAT+ subscribers. That means the full article is gated behind a paywall, and readers who want to see the details of Epic’s model or Omada’s products need to sign up.
For a general audience blog, this means we’re reporting on what the newsletter announces, not on its contents. We know the stories exist, and we know they’re important to the field, but we don’t have the full text of either.
A Week in School, a Week of Illness
The newsletter’s opening anecdote is the headline. A writer whose kids have been in school for one week reports that everyone is already sick. It’s a reminder that health is personal.
The newsletter opens with a story about two kids and their parents, and that’s a smart move. It makes the reader feel seen.
What the Newsletter Covers
The newsletter is a digest of the week’s health technology news. It’s not a deep dive, but it’s a reliable one. The two stories about Epic and Omada are the headline, but there are other items in the newsletter that subscribers can read.
The newsletter is delivered every Tuesday and Thursday to subscriber inboxes. That’s a steady cadence, and it keeps readers engaged without overwhelming them.
The Two Stories Side by Side
The newsletter pairs Epic’s mortality model with Omada’s future products, and the contrast is instructive. Epic is building a tool that predicts death. Omada is building tools that prevent it.
- Epic’s mortality model is a predictive signal that hospitals need to respond to.
- Omada’s future products are hinted at in the newsletter, with no details given.
- Both stories are exclusive to STAT+ subscribers.
The newsletter is doing what it should do. It’s bringing together stories from across the digital health world, and it’s doing it in a way that’s easy to consume.
What We Make of It
The newsletter is a small but effective piece of content marketing. It takes two companies, Epic and Omada, and puts them in the same frame. It’s a way of saying that digital health is a coherent field, not a collection of isolated experiments.
The fact that both stories are exclusive to STAT+ is also significant. It shows that the publication is willing to publish material that isn’t freely available elsewhere.
For readers who are already subscribers, the newsletter is a reminder of what they get. For readers who aren’t, it’s a tease. It’s a way of saying that there’s more to read if you’re willing to pay for it.
The newsletter is doing its job. It’s bringing together stories from across the digital health world, and it’s doing it in a way that’s easy to consume. The pairing of Epic and Omada is a smart one, and it shows the range of what digital health is doing.
The Bottom Line
The newsletter is a small but effective piece of content marketing. It’s a reminder that the field is growing, and that STAT is paying attention. The newsletter is exclusive to STAT+ subscribers, and that’s a decision that makes sense for the publication.
It rewards readers who are already paying, and it gives them a reason to stay. It also gives general readers a reason to consider a subscription, because they know what they’d be missing.
The newsletter is a small but effective piece of content marketing. It’s a reminder that the field is growing, and that STAT is paying attention. The newsletter is exclusive to STAT+ subscribers, and that’s a decision that makes sense for the publication.
The newsletter is doing what it should do. It’s bringing together stories from across the digital health world, and it’s doing it in a way that’s easy to consume.
For a general audience blog, the story is simple: digital health is real, and it’s changing how we think about healthcare. The newsletter is one of the places to keep up with it.
| Day | Delivery |
|---|---|
| Tuesday | Subscriber inbox |
| Thursday | Subscriber inbox |
Source material: “STAT+: Epic’s mortality model, and Omada’s future products,” STAT.
Get the Notebook.
The day's best stories and every fresh verdict, in plain English, in your inbox by seven. One email a day, no more.